Skip to content

AFFILIATES:

  • Arcadia Securities
  • B. Dyson Capital Advisors
  • Tiberius Capital Markets
  • Hermes Capital Advisors
Menu
  • Arcadia Securities
  • B. Dyson Capital Advisors
  • Tiberius Capital Markets
  • Hermes Capital Advisors
Brookline Capital Markets
  • OUR STORY
  • ABOUT THE FIRM
  • TEAM
  • TRANSACTIONS
  • NEWS
  • EQUITY RESEARCH
  • LEGAL DISCLOSURES
  • CONTACT
Menu
  • OUR STORY
  • ABOUT THE FIRM
  • TEAM
  • TRANSACTIONS
  • NEWS
  • EQUITY RESEARCH
  • LEGAL DISCLOSURES
  • CONTACT

Healthcare

Protagenic Follow-On April 21

Read More Protagenic Follow-On April 21Continue

Imunon Capital Markets Advisory Completed Ending Mar 21

Read More Imunon Capital Markets Advisory Completed Ending Mar 21Continue

Scientific Industries Inc.

Read More Scientific Industries Inc.Continue

Adial Pharmaceuticals

Read More Adial PharmaceuticalsContinue

Dermata Therapeutics, Inc.

Read More Dermata Therapeutics, Inc.Continue

Lisata Therapeutics Capital Markets Advisory Ending Aug 21

Lisata Therapeutics Capital Markets Advisory Ending Aug 21

Read More Lisata Therapeutics Capital Markets Advisory Ending Aug 21Continue

Maxona Pharmaceuticals

Read More Maxona PharmaceuticalsContinue

CohBar Inc.

Read More CohBar Inc.Continue

Page navigation

Previous PagePrevious 1 … 22 23 24

HEADQUARTERS

Brookline Capital Markets

600 Lexington Avenue, 30th Floor
New York, New York 10022
(646) 603-6716

Linkedin

LINKS

  • Arcadia Securities
  • B. Dyson Capital Advisors
  • Tiberius Capital Markets
  • Hermes Capital Advisors
  • Arcadia Securities
  • B. Dyson Capital Advisors
  • Tiberius Capital Markets
  • Hermes Capital Advisors
Securities Offered Through Arcadia Securities, LLC – Member FINRA/SIPC

FINRA BROKER CHECK

Arcadia Securities LLC Form CRS

Arcadia Securities LLC Reg BI

Order routing information can be accessed through the following link by inputting Arcadia Securities: https://www.orderroutingdisclosure.com/.

© 2025 Brookline Capital Markets. All rights reserved

© 2021 Brookline Capital Markets. All rights reserved